After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days ...

Animal Drug Safety-Related Labeling Changes | FDA. We remain confident in the safety and effectiveness of Librela and ...

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

In a written Type C response, the FDA confirmed in August of this year that the SOL-R trial should be appropriate for use as Ocular’s second adequate and well-controlled study to support a potential ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

New research points to taking melatonin 3 hours before bedtime but some experts say it is still best to take the supplement ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...